Blood Gas And Electrolyte Analyzer Market 2022 | Top Companies Overview, Regional Analysis, Revenue, CAGR Growth By 2027

(MENAFN- EIN Presswire)

Blood Gas and Electrolyte Analyzer Market Global Report

The global blood gas and electrolyte analyzer market size reached US$ 1.85 Bn in 2021. By 2027, It will reach US$ 2.76 Bn, exhibiting a CAGR of 6.70% (2022-27).

SHERIDAN, WYOMING, UNITED STATES, November 29, 2022 / / -- IMARC Group has recently released a new research study titled“blood gas and electrolyte analyzer market : Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

What are the growth prospects of the blood gas and electrolyte analyzer industry?

The global blood gas and electrolyte analyzer market reached a value of US$ 1.85 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.76 Billion by 2027, exhibiting a growth rate (CAGR) of 6.70% during 2022-2027.

What is blood gas and electrolyte analyzer?

Blood gas and electrolyte analyzers represent the medical devices customized for determining several parameters in a whole blood sample, including potential hydrogen (pH), blood gas (partial pressure of carbon dioxide and oxygen), metabolites, and electrolytes. In terms of modality, they are available in benchtop and portable models. Blood gas and electrolyte analyzer products are effective in detecting metabolic imbalances and the measurement of renal and cardiac functions. They aid in measuring the acid-base balance of a patient, diabetes, drug consumption, etc. Blood gas and electrolyte analyzer instruments are cost-effective and provide accurate and fast results. Consequently, they find extensive applications across various establishments, such as hospitals, clinics, ambulatory surgical centers, etc.

Request and get a sample brochure for free:

Impact of COVID-19:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

What is the major drivers for the blood gas and electrolyte analyzer market?

The escalating number of patients in operating rooms, intensive care units (ICUs), and emergency departments is primarily driving the blood gas and electrolyte analyzer market. Furthermore, the increasing prevalence of chronic diseases among the geriatric population and the elevating demand for high throughput, integrated, and automated systems are acting as significant growth-inducing factors.

Additionally, the growing product usage with laboratory information systems and electronic medical records for streamlining the workflow and enabling effective monitoring of patient health is also positively influencing the market growth. Besides this, the inflating investments by key market players to develop portable product variants with easy-to-use features and minimum maintenance requirements and the shifting preferences toward point-of-care testing (POCT) are expected to propel the blood gas and electrolyte analyzer market over the forecasted period.

Click here to view detailed information with table of content:

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood gas and electrolyte analyzer market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on region, product type, modality and end user.

Breakup by Product Type:

Breakup by Modality:

Breakup by End User:
•Ambulatory Surgical Centers

By Geography:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

List of Major Key Players:
•Abbott Laboratories Inc.
•Dalko Diagnostics
•Erba Group (Transasia Bio-Medicals Ltd.)
•Medica Corporation
•Nova Biomedical Corporation
•OPTI Medical Systems Inc. (IDEXX Laboratories)
•Radiometer Medical ApS (Danaher Corporation)
•Roche Holding AG
•Siemens AG
•WerfenLife S.A.

Other Trending Reports By IMARC Group:

Varicose Vein Treatment Market:

High-Throughput Screening Market:

Enzymes Market Report:

Energy Management System Market:

Cloud-Based Contact Center Market:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.